Here, we substantiated those findings and extended them to breast cancer, where we implicate FasL-expressing MDSCs as part of a broader pathway that links host obesity to heightened CD8 TIL apoptosis and immunotherapy resistance. Here, FASLG is linked to breast carcinoma.